CD26 has shown promise within clinical translation, with data indicating CML LSCs specifically express CD26, with its function disrupting interactions within the stem cell niche [10], and its expression being correlated with both leukocyte count and treatment response [8]. Here, DPP4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.